Publication | Open Access
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
196
Citations
19
References
2015
Year
Rapid and durable hematologic and molecular responses were observed in patients with essential thrombocythemia who received imetelstat. (Funded by Geron; ClinicalTrials.gov number, NCT01243073.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1